A Variant of TNFR2-Fc Fusion Protein Exhibits Improved Efficacy in Treating Experimental Rheumatoid Arthritis

Etanercept, a TNF receptor 2-Fc fusion protein, is currently being used for the treatment of rheumatoid arthritis (RA). However, 25% to 38% of patients show no response which is suspected to be partially due to insufficient affinity of this protein to TNFα. By using computational protein design, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tong, Wang, Zheng, Wu, Fang, Tan, Jingwei, Shen, Yijun, Li, Erguang, Dai, Jingzhi, Shen, Ronghai, Li, Gang, Wu, Jinsong, Wang, Luochun, Wang, Haibo, Liu, Yanjun
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816690/
https://www.ncbi.nlm.nih.gov/pubmed/20140191
http://dx.doi.org/10.1371/journal.pcbi.1000669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816690/
https://www.ncbi.nlm.nih.gov/pubmed/20140191
http://dx.doi.org/10.1371/journal.pcbi.1000669

Ejemplares similares